European Hematology Association, American Society of Hematology, and the European Cancer Patient Coalition Issue an International Call to Action to Alleviate Drug Shortages
AMSTERDAM, June 18, 2012 /PRNewswire/ –
The European Hematology Association (EHA), the American Society of Hematology (ASH),
and the European Cancer Patient Coalition (ECPC) joined in issuing a common call to action
in an effort to mitigate shortages of hematologic drugs in Europe, the United States and
around the world. The collective made the announcement today following the EHA-ASH Joint
Symposium at the 17th EHA Congress in Amsterdam which was dedicated to the drug shortage
The common call to action seeks first to raise awareness of shortages of drugs among
hematologists. Shortages of drugs worldwide have particularly affected hematologists and
their patients since the drugs most vulnerable to shortages are the ones used to treat
life threatening blood disorders.
The international collaborative will also collect data on current drug shortages and
report it to their health authorities. EHA, ASH, and ECPC will issue reports to their
respective government authorities about current drug shortages in an effort to bolster the
supply of critically needed drugs in the most efficient, effective manner.
Finally, the collaborative pledged to support legislation in the United States,
Europe, and around the world that provides clear, effective interventions to alleviate
“In the United States, legislation is well under way that may curb drug shortages,”
said Ulrich Jager, president of EHA, “but in Europe we do not even have a proper
understanding of the scope of the problem. We must work together with our partners to
raise awareness and protect the health of patients with blood disorders worldwide.”
About the EHA Annual Congress
After 16 congresses and constantly increasing number of delegates, the 17th Congress
of EHA was taking place in Amsterdam. Hematology is a specialty that covers everything to
do with blood: its origin in the bone marrow, diseases (in the production) of blood and
their treatments. The latest data on research and developments within the wide spectrum of
hematology are presented.
About the European Hematology Association
EHA is an NGO that promotes excellence in clinical practice, research and education in
European hematology. EHA is the representative of hematology and hematologists in Europe.
Further information can be found at http://www.ehaweb.org
SOURCE European Hematology Association